Fundraising Fox

Siobhan Nolan Mangini

Partner at Venrock

Palo Alto

About

Siobhan Nolan Mangini is a Partner at Venrock who invests in early-stage healthcare and technology companies. She supports portfolio companies through strategic guidance, financing strategies, business development, and operational support.

Experience

  1. VenrockPartnercurrent2025 β€” present
  2. Cityblock HealthMember Board of Directorscurrent2024 β€” present
  3. Alight SolutionsMember Board of Directorscurrent2024 β€” present
  4. Virta HealthMember Board of Directorscurrent2023 β€” present
  5. SmithRxMember Board of Directorscurrent2023 β€” present
  6. Marathon HealthMember Board of Directors2021 β€” 2026
  7. Delflorien LabsFounder2024 β€” 2025
  8. January VenturesOperator Network2018 β€” 2025
  9. NGM BiopharmaceuticalsPresident & Chief Financial Officer2022 β€” 2023
  10. NGM BiopharmaceuticalsChief Financial Officer2020 β€” 2022
  11. Artemis HealthMember Board of Directors2020 β€” 2022
  12. Castlight HealthAdvisor2020
  13. Castlight HealthPresident & CFO2019 β€” 2020
  14. Castlight HealthChief Financial Officer2016 β€” 2019
  15. Castlight HealthVice President, Finance & Business Operations2015 β€” 2016San Francisco
  16. Castlight HealthSenior Director, Operations and Financial Planning2014 β€” 2015
  17. Castlight HealthDirector, Strategy & Business Development2012 β€” 2014
  18. Bain & CompanyCase Team Leader2009 β€” 2012
  19. Acumen FundPortfolio Intern2009
  20. Bain & CompanySummer Associate2008

Education

  1. Stanford University Graduate School of BusinessMBA
  2. Harvard Kennedy SchoolMPA
  3. The Wharton SchoolBS Econ, Finance

Skills & more

Cross-functional Team Leadership13Venture Capital21Corporate Development11Due Diligence14Private Equity13Business Strategy13Business Development9Start-ups3Finance2Portfolio Management2Financial Modeling3Investor Relations2
+5 moreForecastingExecutive ManagementStrategyStrategic PlanningLeadership

From Siobhan's professional profile.

Deals Β· 1

Smith HealthBoard seat

via Venrock Β· filed Feb 2024 Β· $60M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Venrock